HEMATOLOGIC OUTCOMES AND DOSING PATTERNS IN ANEMIC PATIENTS WITH PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD) SWITCHING FROM DARBEPOETIN ALFA (DARB) TO EPOETIN ALFA (EPO)

被引：0
|
作者：
Hura, Claudia [1 ]
Jackson, James [2 ]
Lunacsek, Orsolya [2 ]
Bailey, Robert A. [3 ]
McKenzie, R. Scott [3 ]
机构：
[1] San Antonio Kidney Dis Ctr, San Antonio, TX USA
[2] Xcenda LLC, Palm Harbor, FL USA
[3] Centocor Ortho Biotech Serv LLC, Horsham, PA USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2010年 / 55卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
133
引用
收藏
页码：A65 / A65
页数：1
相关论文
共 50 条
  • [31] Hemoglobin Variability With Extended Dosing of Epoetin Alfa in Patients With Chronic Kidney Disease and Not on Dialysis
    Bailey, Robert A.
    McGowan, Tracy
    Tang, K. Linda
    Langholff, Wayne K.
    Lantz, Keith C.
    Wolfson, Marsha
    DIALYSIS & TRANSPLANTATION, 2009, 38 (10) : 407 - +
  • [32] COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN A CHRONIC KIDNEY DISEASE POPULATION TREATED IN THE HOSPITAL INPATIENT AND OUTPATIENT SETTING
    Lafeuille, Marie-Helene
    Bailey, Robert A.
    Senbetta, Mekre
    Lefebvre, Patrick
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A56 - A56
  • [33] Real-world epoetin alfa (EPO) and darbepoetin alfa (DARB) dosing and cost considerations in elderly hospital inpatients: Results from a large observational study
    Duh, M.
    Vekeman, F.
    Mckenzie, R. S.
    Lefebvre, P.
    Watson, S.
    Mody, S.
    Piech, C. T.
    VALUE IN HEALTH, 2007, 10 (03) : A131 - A131
  • [34] Extended intervals using epoetin alfa in pre-dialysis patients with chronic kidney disease (CKD) appears to be limited to patients with low dose requirements.
    Wish, J
    Law, AW
    Schulman, KL
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A62 - A62
  • [35] Dosing intervals and hemoglobin control in patients with chronic kidney disease and anemia treated with epoetin alfa or darbepoetin alfa: A retrospective cohort study
    Nurko, Saul
    Spirko, Rita
    Law, Amy
    Dennis, Vincent W.
    CLINICAL THERAPEUTICS, 2007, 29 (09) : 2010 - 2021
  • [36] Exposure-Response Modeling of Darbepoetin Alfa in Anemic Patients With Chronic Kidney Disease Not Receiving Dialysis
    Doshi, Sameer
    Chow, Andrew
    Perez Ruixo, Juan Jose
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 75S - 90S
  • [37] An examination of direct and indirect employer costs associated with epoetin alfa treatment in pre-dialysis chronic kidney disease patients
    Bookhart, Brahim K.
    Papatheofanis, Frank
    Chawla, Namrita
    Muser, Erik
    Piech, Catherine Tak
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A31 - A31
  • [38] Extended dosing with darbepoetin alfa in patients with chronic kidney disease on hemodialysis
    Amico, Patrizia
    Dickenmann, Michael
    Steiger, Juerg
    Saldutto, Biagio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 154 - 154
  • [39] Effect of anemia treatment with epoetin alfa or darbepoetin alfa on left ventricular mass in patients with chronic kidney disease not on dialysis in Japan.
    Suzuki, Makoto
    Akaishi, Makoto
    Hada, Yoshiyuki
    Hiroe, Michiaki
    Aonuma, Kazutaka
    Tsubakihara, Yoshiharu
    Akizawa, Tadao
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 67A - 67A
  • [40] CONVERSION FROM EPOETIN ALFA TO DARBEPOETIN ALFA IN HEMODIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE: FRENCH MONOCENTRE OBSERVATIONAL STUDY
    Binaut, R.
    Bacri, J. L.
    Fleury, D.
    Maisonneuve, N.
    Labatut, D.
    Lemaitre, V
    Medeghri, Z.
    Bir, G.
    Lanier, J.
    VALUE IN HEALTH, 2012, 15 (07) : A458 - A459
12345